TMOON
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Meno TMOON
Pozícia No.3563
Trhová kapitalizácia $0.00
Plne zriedená trhová hodnota $0.00
Podiel na trhu %
Objem obchodovania/trhová kapitalizácia (24 h) 5,738,296.29%
Počet coinov v obehu 12.13351162
Max. počet coinov v obehu 0
Celková ponuka 12.13351162
Rýchlosť obehu %
Dátum vydania --
Cena, za ktorú bolo aktívum prvýkrát vydané --
Celkové maximum 643.187233444486, 2026-01-22
Najnižšia cena 437.1989421522778, 2026-05-18
Verejný blockchain TMOON
Úvod Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Sektor
Sociálne siete
Analýza toku finančných prostriedkov
|
Kúpiť(TMOON) |
Predať(TMOON) |
Čistý prílev |
| Veľký |
0.000 |
0.000 |
0.000 |
| Stredná |
0.000 |
0.000 |
0.000 |
| Malý |
12.480 |
5.635 |
6.844 |
| Celkom |
12.480 |
5.635 |
6.844 |
etfindex:mc_etfindex_source Odmietnutie zodpovednosti: Údaje, ktoré poskytuje cmc a ktoré by sa nemali považovať za investičné poradenstvo.
